152 related articles for article (PubMed ID: 20091648)
1. Management of drainage for malignant ascites in gynaecological cancer.
Keen A; Fitzgerald D; Bryant A; Dickinson HO
Cochrane Database Syst Rev; 2010 Jan; (1):CD007794. PubMed ID: 20091648
[TBL] [Abstract][Full Text] [Related]
2. Management of drainage for malignant ascites in gynaecological cancer.
Kietpeerakool C; Rattanakanokchai S; Jampathong N; Srisomboon J; Lumbiganon P
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD007794. PubMed ID: 31825525
[TBL] [Abstract][Full Text] [Related]
3. Exenterative surgery for recurrent gynaecological malignancies.
Ang C; Bryant A; Barton DP; Pomel C; Naik R
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010449. PubMed ID: 24497188
[TBL] [Abstract][Full Text] [Related]
4. Palliative surgery versus medical management for bowel obstruction in ovarian cancer.
Kucukmetin A; Naik R; Galaal K; Bryant A; Dickinson HO
Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD007792. PubMed ID: 20614464
[TBL] [Abstract][Full Text] [Related]
5. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.
Eleje GU; Eke AC; Igberase GO; Igwegbe AO; Eleje LI
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011000. PubMed ID: 25932968
[TBL] [Abstract][Full Text] [Related]
6. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in women with gynaecological malignancies.
Charoenkwan K; Kietpeerakool C
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007387. PubMed ID: 28660687
[TBL] [Abstract][Full Text] [Related]
7. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in patients with gynaecological malignancies.
Charoenkwan K; Kietpeerakool C
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD007387. PubMed ID: 24894643
[TBL] [Abstract][Full Text] [Related]
8. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.
Eleje GU; Eke AC; Igberase GO; Igwegbe AO; Eleje LI
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011000. PubMed ID: 30888060
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen for relapse of ovarian cancer.
Williams C; Simera I; Bryant A
Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD001034. PubMed ID: 20238312
[TBL] [Abstract][Full Text] [Related]
10. Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in patients with gynaecological malignancies.
Charoenkwan K; Kietpeerakool C
Cochrane Database Syst Rev; 2010 Jan; (1):CD007387. PubMed ID: 20091631
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease.
Abdul Razak AR; Li L; Bryant A; Diaz-Padilla I
Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD007584. PubMed ID: 21412906
[TBL] [Abstract][Full Text] [Related]
12. Patient-reported outcome measures for follow-up after gynaecological cancer treatment.
Nama V; Nordin A; Bryant A
Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD010299. PubMed ID: 24249483
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer.
Galaal K; Naik R; Bristow RE; Patel A; Bryant A; Dickinson HO
Cochrane Database Syst Rev; 2010 Jun; 2010(6):CD007822. PubMed ID: 20556785
[TBL] [Abstract][Full Text] [Related]
14. Follow-up protocols for women with cervical cancer after primary treatment.
Lanceley A; Fiander A; McCormack M; Bryant A
Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD008767. PubMed ID: 24277645
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma.
Shylasree TS; Bryant A; Athavale R
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006246. PubMed ID: 23450567
[TBL] [Abstract][Full Text] [Related]
16. Interventions for the treatment of Paget's disease of the vulva.
Edey KA; Allan E; Murdoch JB; Cooper S; Bryant A
Cochrane Database Syst Rev; 2013 Oct; (10):CD009245. PubMed ID: 24163070
[TBL] [Abstract][Full Text] [Related]
17. Lymphadenectomy for the management of endometrial cancer.
May K; Bryant A; Dickinson HO; Kehoe S; Morrison J
Cochrane Database Syst Rev; 2010 Jan; (1):CD007585. PubMed ID: 20091639
[TBL] [Abstract][Full Text] [Related]
18. Palliative long-term abdominal drains versus repeated drainage in individuals with untreatable ascites due to advanced cirrhosis: study protocol for a feasibility randomised controlled trial.
Macken L; Mason L; Evans C; Gage H; Jordan J; Austin M; Parnell N; Cooper M; Steer S; Boles J; Bremner S; Lambert D; Crook D; Earl G; Timeyin J; Verma S
Trials; 2018 Jul; 19(1):401. PubMed ID: 30053891
[TBL] [Abstract][Full Text] [Related]
19. DNA-repair pathway inhibitors for the treatment of ovarian cancer.
Martinek I; Haldar K; Gaitskell K; Bryant A; Nicum S; Kehoe S; Morrison J
Cochrane Database Syst Rev; 2010 Jun; (6):CD007929. PubMed ID: 20556786
[TBL] [Abstract][Full Text] [Related]
20. PleurX drain use in the management of malignant ascites: safety, complications, long-term patency and factors predictive of success.
Tapping CR; Ling L; Razack A
Br J Radiol; 2012 May; 85(1013):623-8. PubMed ID: 21427184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
